Common adverse effects are predominantly gastrointestinal and typically emerge during dose escalation: Nausea (affecting 2050% of users initially) Vomiting and diarrhoea Constipation Abdominal pain and bloating Reduced appetite (therapeutic effect but may be excessive) Fatigue and headache Injection site reactions (redness, swelling or itching) These effects usually diminish over several weeks as the body adjusts
The degree of change in skin tone, if any, varies considerably between individuals and is not predictable
Designed for all skin types
Products are not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of any disease, nor for any clinical, diagnostic, or therapeutic use
Conagra Brands On Track badge Conagra Brands was among the earliest CPG manufacturers to add GLP-1 to its labels